Home › Funds › CLARK ESTATES INC/NY › SOLV

CLARK ESTATES INC/NY position in SOLV

SOLVENTUM CORP · Health Care

CLARK ESTATES INC/NY reported holding 160,000 shares of SOLV (SOLVENTUM CORP) in its Q3 2026 13F filing — a position valued at US$14.1M, representing 3.28% of its reported portfolio and ranking #11 among its reported holdings. CLARK ESTATES INC/NY has disclosed SOLV holdings in 6 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)160.00K sh
Reported value held$14.10M
Portfolio Weight3.28%
First reportedQ1 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CLARK ESTATES INC/NY's SOLV position evolved

CLARK ESTATES INC/NY first disclosed a stake in SOLV in Q1 2024 at 135,000 shares (US$9.4M). The position peaked in Q1 2026 at 290,000 shares, worth US$18.9M. Across 6 filings, CLARK ESTATES INC/NY increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 160,000 shares valued at US$14.1M — a reduction of -40,000 shares quarter over quarter.. Notable position changes include a 39% increase in Q4 2025 (shares fell 18% over the following quarter), a 35% increase in Q1 2026 (shares rose 18% over the following quarter), a 31% trim in Q2 2026 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 135.00K $9.39M New
Q3 2025 155.00K $11.31M New
Q4 2025 215.00K $17.04M Add
Q1 2026 290.00K $18.94M Add
Q2 2026 200.00K $15.43M Reduce
Q3 2026 160.00K $14.10M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SOLV and 13F data

SOLV (SOLVENTUM CORP) is a Health Care company. 41 other funds we track also report a position in SOLV — the largest reported positions include Independent Franchise Partners LLP (US$1.38B), TRIAN FUND MANAGEMENT, L.P. (US$635.5M), DAVIS SELECTED ADVISERS (US$565.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SOLV

All SOLV fund holders →

FAQ

How long has CLARK ESTATES INC/NY held SOLV?

CLARK ESTATES INC/NY has disclosed SOLV holdings in 6 of the last 11 reported quarters, going back to Q1 2024.

What is CLARK ESTATES INC/NY's current position in SOLV?

As of Q3 2026, CLARK ESTATES INC/NY holds 160.00K shares of SOLV (SOLVENTUM CORP), valued at $14.10M, representing 3.28% of its reported portfolio and ranking #11.

Has CLARK ESTATES INC/NY been buying or selling SOLV?

In the latest 13F filing (Q3 2026), CLARK ESTATES INC/NY reduced its position in SOLV. The position peaked in Q1 2026 at 290.00K shares.

Which other funds hold SOLV?

Other major institutional holders of SOLV include Independent Franchise Partners LLP, TRIAN FUND MANAGEMENT, L.P., DAVIS SELECTED ADVISERS, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.